If you are reading this, you have probably already tried the obvious things and they have not held.
Here is what nobody tells you at the pharmacy counter: recurrent yeast is a recognised clinical problem that medicine does not reliably solve. That is not a reason to give up, and it is important context for every promise you will read about it, including the ones on product pages.
In this article
- What counts as recurrent
- The honest state of the evidence
- Why the standard approach often fails
- Two things worth ruling out first
- What the guidelines recommend
- What you can control
- What does not work
- How to have a better appointment
- Frequently asked questions
What counts as recurrent
Generally four or more episodes in twelve months, with symptoms confirmed rather than assumed.
Recurrent vulvovaginal candidiasis, RVVC, is described as a chronic, difficult to treat infection affecting women of all ages and backgrounds, with prevalence as high as 9%.
Nearly one woman in eleven. It is not rare and it is not something you are doing wrong.
The honest state of the evidence
This section is the reason this article exists, and it is the part product marketing removes.
The CDC-recommended first-line maintenance regimen is oral fluconazole, 100, 150 or 200mg, weekly for six months.
And here is what happens after.
- Up to 57% of patients relapse within three to six months of ceasing treatment
- Recurrence after stopping fluconazole maintenance has been reported as high as 71.9% at six months
- The regimen "frequently fails to cure the condition and serves only as an effective control measure"
So the standard of care controls symptoms while you are on it, and roughly two thirds of women relapse within six months of stopping.
That is the actual picture. Anyone selling you something that promises to break the cycle is promising what the best available treatment does not reliably deliver.
Why the standard approach often fails
Three documented reasons, and they change what you should ask for.
It may not be albicans. Non-albicans Candida species are frequently dose-dependent susceptible or resistant to fluconazole and other azoles, and their prevalence is rising. If treatment is not working, the species matters, and identifying it requires a culture rather than a symptom-based prescription.
Repeated azole exposure has consequences. Clinical resistance remains rare, but overexposure to azoles may increase development of fluconazole-resistant C. albicans strains. Treating repeatedly without confirming carries a cost.
Treatment affects the wider microbiome. Research into fluconazole's impact on both fungal and bacterial populations, at vaginal and gastrointestinal sites, is an active area precisely because the interaction is not simple.
Two things worth ruling out first
Before another course of anything.
First: is it actually yeast? This is the most valuable question in the article.
Symptoms overlap heavily with other conditions, and repeated negative tests are meaningful information rather than bad luck. The main alternatives:
- Contact irritation from soaps, wipes or detergent. Very common, fully reversible, and mistaken for thrush constantly. Detail here.
- Genitourinary syndrome of menopause, which produces itching and irritation and is regularly treated as recurrent thrush for years.
- Lichen sclerosus, which causes intense itching and needs completely different treatment.
- Bacterial vaginosis, which is a bacterial rather than fungal shift.
Second: is something driving it? Diabetes, immune suppression, repeated antibiotic courses, and hormonal factors all raise risk and are worth investigating rather than treating around.
What the guidelines recommend
Confirm it. A culture, not a symptom-based prescription, particularly if previous treatment has failed. Species identification changes what works.
Induction then maintenance. Clearing the acute episode, then a maintenance regimen, typically weekly fluconazole for six months.
Topical options exist and there is an expert consensus on topical treatment of RVVC, which matters for anyone who cannot take oral azoles.
Expect to discuss what happens after maintenance, given the relapse figures. That conversation is more useful had at the start than at month seven.
What you can control
None of this replaces treatment. All of it reduces the load.
Stop the things that raise pH and strip the barrier. Soap, douching, scented products, overwashing. The cleansing routine matters more here than almost anywhere.
Manage moisture. Cotton, change out of damp clothing, avoid tight synthetics for long periods.
Laundry. Unscented detergent, no fabric softener on underwear, double rinse.
Protect the barrier. Skin that is repeatedly inflamed and repeatedly treated is skin with a compromised barrier, and that makes everything more reactive. A balm formulated for this tissue supports comfort between episodes. To be explicit: that is barrier support, not treatment.
Do not self-treat repeatedly without confirmation. It is the single most common way women spend two years not finding out what they actually have.
What does not work
- Yoghurt, internally or externally. No good evidence, and it introduces sugar and bacteria into an environment being managed.
- Garlic. No evidence, real reports of chemical burns.
- Tea tree oil undiluted. A recognised irritant and sensitiser on mucosal skin.
- Douching, which ACOG advises against and which makes recurrence more likely.
- Coconut oil. In-vitro lauric acid activity does not translate into clinical resolution, and there is a pH problem.
- Cutting all sugar. Popular, and not supported by good evidence for non-diabetic women.
The uncomfortable common thread: if any of these worked reliably, the relapse rates on actual antifungal maintenance would not be what they are.
How to have a better appointment
Bring specifics and ask directly.
- A record of episodes: dates, symptoms, what was used, what happened
- Ask for a culture with species identification, not a symptom-based prescription
- Ask whether it could be something else, and name the alternatives above
- Ask whether anything underlying should be checked
- Ask what the plan is after maintenance ends
- Ask for referral to a specialist vulval clinic if you have been going in circles
Being specific gets better care. "It keeps coming back" gets a repeat prescription. "Four confirmed episodes, two negative cultures, no response to fluconazole" gets a different conversation.
Frequently asked questions
What counts as recurrent thrush?
Generally four or more episodes in twelve months. It affects as many as 9% of women in some populations, so it is common rather than unusual, and it is recognised clinically as difficult to treat.
Why does it keep coming back after treatment?
Maintenance treatment controls symptoms while you take it, and relapse after stopping is common. Up to 57% relapse within three to six months of ceasing, and one reported figure is 71.9% recurrence at six months. It may also be a non-albicans species that fluconazole does not cover, which needs a culture to identify.
Could it be something other than yeast?
Frequently, yes. Contact irritation from soaps and wipes, genitourinary syndrome of menopause, lichen sclerosus and bacterial vaginosis all produce similar symptoms. Repeated negative tests are information worth acting on rather than dismissing.
Do natural remedies work for recurring yeast?
There is no good evidence for yoghurt, garlic or coconut oil resolving established infection, and garlic and undiluted tea tree oil carry real risk of chemical burns and irritation. Given that proper antifungal maintenance has high relapse rates, claims that a home remedy breaks the cycle should be treated sceptically.
Does sugar cause yeast infections?
The link is weaker than commonly claimed for women without diabetes. Poorly controlled diabetes is a genuine risk factor and worth investigating. Eliminating all sugar as a treatment is not well supported.
Should I ask for a culture?
Yes, particularly if treatment has failed before. Non-albicans species are frequently resistant to fluconazole and are becoming more common, and only a culture with species identification tells you which one you are treating.
Sources
- Management of recurrent vulvovaginal candidosis, narrative review and European expert panel opinion: PMC9504472
- Fluconazole use and fungal and bacterial microbiomes in RVVC: PMC11754358
- Topical treatment of recurrent vulvovaginal candidiasis, expert consensus: PMC8812501
- Douching guidance: ACOG